跳至主要内容
临床试验/NCT03507010
NCT03507010进行中(未招募)3 期

Ledderhose Disease: Radiotherapy or Not? A Randomised, Multicentre, Prospective, Double Blind Phase III Trial Investigating the Effect of Radiotherapy on Patients With Ledderhose Disease

University Medical Center Groningen2 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2018年1月23日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
入组人数
84
试验地点
2
主要终点
Numeric Rating Scale

研究概览

简要总结

The aim of the LedRad trial is to determine the efficacy and durability of radiotherapy as treatment for patients with Ledderhose disease and to compare this to the natural course of Ledderhose disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with painful Ledderhose disease. The pain score measured with the VAS score and is at least 2 on the 11-point scale (0 = no pain to 10 = worst imaginable pain).
  • Age ≥ 18 years
  • WHO performance status 0, 1 or 2 (Appendix, section 18)
  • Before patient randomisation, written informed consent must be given according to ICH/GCP, and WMO requirements.
  • Controlling the Dutch language (speaking and reading).
  • Able and willing to complete quality of life questionnaires in Dutch
  • Must be accessible for treatment follow-up

排除标准

  • Surgical intervention before for Ledderhose disease
  • Previous radiation treatment for Ledderhose disease
  • Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
  • Not able to lay prone for at least fifteen minutes
  • Females who are pregnant at entry or who want to become pregnant within six months.

结局指标

主要结局

Numeric Rating Scale

时间窗: 12 months

Determine pain with the Numeric Rating Scale

次要结局

  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0(18 months)
  • Numeric Rating Scale(6 and 18 months)
  • Walking motion(12 months)
  • Walking distance(6, 12 and 18 months)
  • Quality of life (1)(6, 12 and 18 months)
  • Quality of life (2)(6, 12 and 18 months)
  • Quality of life (3)(6, 12 and 18 months)
  • Size of ledderhose nodules(12 months)
  • Cost-effectiveness analysis (CEA)(6, 12 and 18 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验